×
  • Select the area you would like to search.
  • ACTIVE INVESTIGATIONS Search for current projects using the investigator's name, institution, or keywords.
  • EXPERTS KNOWLEDGE BASE Enter keywords to search a list of questions and answers received and processed by the ADNI team.
  • ADNI PDFS Search any ADNI publication pdf by author, keyword, or PMID. Use an asterisk only to view all pdfs.
Filter results by:

3393 Total Publications

Anxiety is related to Alzheimer cerebrospinal fluid markers in subjects with mild cognitive impairment
Ramakers IH1, Verhey FR, Scheltens P, Hampel H, Soininen H, Aalten P, Rikkert MO, Verbeek MM, Spiru L, Blennow K, Trojanowski JQ, Shaw LM, Visser PJ; Alzheimer's Disease Neuroimaging Initiative and DESCRIPA Investigators.
PMID: 22954311 ; PMCID:4104501 ; 2013; Journal Neurology; vol. 43; no. 5; pp. 911-20; doi:10.1017/S0033291712001870
Mitochondrial Haplotypes Associated with Biomarkers for Alzheimer’s Disease
Ridge, P. G., Koop, A., Maxwell, T. J., Bailey, M. H., Swerdlow, R. H., Kauwe, J. S. K., & Honea, R. a.
PMID: 24040196 ; PMCID:3770576 ; 2013; Journal PloS One; vol. 8; no. 9; pp. e74158; doi:10.1371/journal.pone.0074158
Functional activities questionnaire items that best predict disease progression in the clinically normal elderly.
G., M., A., Z., N., L., R., A., J., L., K., J., … D., R.
2013; Journal Alzheimer's and Dementia;
White matter hyperintensities and amyloid are independently associated with entorhinal cortex volume among individuals with mild cognitive impairment.
Guzman, V. a., Carmichael, O. T., Schwarz, C., Tosto, G., Zimmerman, M. E., & Brickman, A. M.
2013; Journal Alzheimer's and Dementia; vol. 9; no. 5; pp. S124-S131; doi:10.1016/j.jalz.2012.11.009
Discriminative Feature Selection for Uncertain Graph Classification.
Kong X, Yu P, Wang X, Ragin A.
2013; Journal arXiv Prepr; vol. 2013; pp. 82-93;
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease.
Lambert, J. C., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., … Amouyel, P.
2013; Journal Nature Genetics; vol. 45; no. 12; pp. 1452-8; doi:10.1038/ng.2802
Visual ratings of atrophy in MCI: Prediction of conversion and relationship with CSF biomarkers.
Lehmann, M., Koedam, E. L., Barnes, J., Bartlett, J. W., Barkhof, F., Wattjes, M. P., … Fox, N. C.
2013; Journal Neurobiology of Aging; vol. 34; no. 1; pp. 73-82; doi:10.1016/j.neurobiolaging.2012.03.010
Relationship between imaging biomarkers, age, progression and symptom severity in Alzheimer’s disease.
Dukart, J., Mueller, K., Villringer, A., Kherif, F., Draganski, B., Frackowiak, R., & Schroeter, M. L.
2013; Journal Neuroimage: Clinical; vol. 3; pp. 84-94; doi:10.1016/j.nicl.2013.07.005
Heart fatty acid binding protein and Aβ-associated Alzheimer’s neurodegeneration.
Rahul S Desikan, Wesley K Thompson, Dominic Holland, Christopher P Hess, James B Brewer, Henrik Zetterberg, Kaj Blennow, Ole A Andreassen, Linda K McEvoy, Bradley T Hyman, Anders M Dale, and for the Alzheimer’s Disease Neuroimaging Initiative.
2013; Journal Molecular Neurodegeneration; vol. 8; no. 39; doi:10.1186/1750-1326-8-39